| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 11/24/2005 | US20050261277 Pentacyclic oxepines and derivatives thereof, compositions and methods |
| 11/24/2005 | US20050261271 Dipeptidyl peptidase inhibitors |
| 11/24/2005 | US20050261269 New derivatives of amidines, their preparation, their use as medicaments and the pharmaceutical compositions containing them |
| 11/24/2005 | US20050261268 For therapy of allergic disorders, proliferative disorders, autoimmune disorders, conditions associated with organ transplant, inflammatory disorders, immunologically mediated disorders, viral diseases, or destructive bone disorders |
| 11/24/2005 | US20050261260 Combination of a CDK inhibitor and mitoxantrone |
| 11/24/2005 | US20050261252 LPA receptor agonists and antagonists and methods of use |
| 11/24/2005 | US20050261248 New-4-pyrrolopyrimidin-6-YL)benzenesulphonamide derivatives |
| 11/24/2005 | US20050261235 2' ,5' -Oligoadenylate analogs |
| 11/24/2005 | US20050261220 Tumor treating combinations, compositions and methods |
| 11/24/2005 | US20050261186 NRG-2 nucleic acid molecules, polypeptides, and diagnostic and therapeutic methods |
| 11/24/2005 | US20050261178 Administering to patient therapeutic dose of cytokine in combination with antibodies directed against tumor associated antigen carbonic anhydrase IX (CAIX/G250/MN); method characterized in significantly reduced cytokine-related toxicity combined with potentiated effectiveness of anti-G250 antibody alone |
| 11/24/2005 | US20050261162 Pharmaceutical composition for preventing and treating cancer and treating an inflammation |
| 11/24/2005 | US20050260732 Polypeptide crystal having a polyhistidine tag added to the C-terminal end; effectors; drug screening for enzyme inhibitors; multiple sclerosis, diabetes, Grave's disease, rheumatic arthritis, AIDS, cancer, immunomodulators |
| 11/24/2005 | US20050260644 Cell signaling proteins |
| 11/24/2005 | US20050260616 Nucleotide and protein sequences of Nogo genes and methods based thereon |
| 11/24/2005 | US20050260601 Recombinant mutants of rhabdovirus and methods of use thereof |
| 11/24/2005 | US20050260582 Cell proliferation inhibitors comprising ets transcription factor or gene encoding the same |
| 11/24/2005 | US20050260560 Administering antigens capable of causing specific immune reaction(s) directed against an infectious agent and/or cells infected with the infectious agent, and decreasing a different specific immune reaction direct towards the infectious agent, infected cells and/or uninfected cells; immunotherapy |
| 11/24/2005 | US20050260555 Chemosensitivity measurement using caspase activity |
| 11/24/2005 | US20050260292 Sovent extraction of hemagglutinin specific for acetyl-D-galactosamine residues of O-glycosidically linked oligosaccharide of glycophorin A by homogenizing seeds with a homogenizing agent comprising phosphate-buffered saline and glycine;centrifuging and filtering to collect supernatant; antitumor agent |
| 11/24/2005 | US20050260290 Botanical anti-inflammatory compositions and methods |
| 11/24/2005 | US20050260283 Composition for prevention and treatment of colon adenomas |
| 11/24/2005 | US20050260277 Method and formula for anti-tumor and anti-matastatic effect |
| 11/24/2005 | US20050260261 Neutral-cationic lipid for nucleic acid and drug delivery |
| 11/24/2005 | US20050260234 Anti-neovasculature preparations for cancer |
| 11/24/2005 | US20050260231 treating a mammary gland disorder, including hyperplastic, hypertonic, cystic and/or neoplastic mammary gland tissue by local administration of a botulinum toxin to or to the vicinity of the afflicted breast tissue |
| 11/24/2005 | US20050260227 Novel therapeutic processes for treating cancer with specific antigens |
| 11/24/2005 | US20050260226 Novel therapeutic processes for treating infectious agents by training or adoptive transfer of immune cells, and useful compositions therefor |
| 11/24/2005 | US20050260209 Ephrin-b receptor protein involved in carcinoma |
| 11/24/2005 | US20050260208 Binding agents and their use in targeting tumor cells |
| 11/24/2005 | US20050260207 Monoclonal antibody neutralising cathepsin b activity and uses thereof |
| 11/24/2005 | US20050260206 Drugs containing genetically modified antibody against ganglioside gd3 |
| 11/24/2005 | US20050260169 Treatment of cancer using HSV mutant |
| 11/24/2005 | CA2820168A1 Identification of surface-associated antigens for tumor diagnosis and therapy |
| 11/24/2005 | CA2567154A1 Novel pyridazinone derivatives as inhibitors of cdk2 |
| 11/24/2005 | CA2566707A1 Pyrimidine derivatives for the treatment of abnormal cell growth |
| 11/24/2005 | CA2566477A1 Pyrimidine derivatives for the treatment of abnormal cell growth |
| 11/24/2005 | CA2566332A1 Pyrimidine derivatives for the treatment of abnormal cell growth |
| 11/24/2005 | CA2566180A1 Use of targeted oxidative therapeutic formulation in treatment of cancer |
| 11/24/2005 | CA2565189A1 Cis-2,4,5-triphenyl imidazolines and their use as anti-cancer medicaments |
| 11/24/2005 | CA2564325A1 Substituted pyrazolyl urea derivatives useful in the treatment of cancer |
| 11/24/2005 | CA2564199A1 Pyrimidine derivatives for the treatment of abnormal cell growth |
| 11/24/2005 | CA2563305A1 Combination therapies for cancer and proliferative angiopathies |
| 11/24/2005 | CA2562572A1 Camptothecin derivatives conjugated in position 20 with integrin antagonists |
| 11/24/2005 | CA2562569A1 7-t-butoxyiminomethylcamptothecin conjugated in position 20 with integrin antagonists |
| 11/24/2005 | CA2561859A1 Beta-carbolines useful for treating inflammatory disease |
| 11/23/2005 | EP1598419A1 Monoclonal antibody, gene encoding the same, hybridoma, medicinal composition and diagnostic reagent |
| 11/23/2005 | EP1598369A1 Antibody and use thereof |
| 11/23/2005 | EP1598356A1 Method for preparing polymorphism of irinotecan hydrochloride |
| 11/23/2005 | EP1598352A1 1-Glyoxylamide indolizines for treating cancer |
| 11/23/2005 | EP1598346A1 Process for producing acid adduct salt of polyacidic base compound |
| 11/23/2005 | EP1598071A1 Superoxide anion decomposing agent |
| 11/23/2005 | EP1598067A1 Carbamic acid compounds comprising an amide linkage as HDAC inhibitors |
| 11/23/2005 | EP1597587A2 Diagnostics and therapeutics for diseases associated with g-protein coupled receptor hm74a (hm74a) |
| 11/23/2005 | EP1597366A1 Modulation of insulin like growth factor i receptor expression |
| 11/23/2005 | EP1597354A2 System for external control of oncolytic virus replication |
| 11/23/2005 | EP1597302A1 Polymer guanidine derivatives as a cytostatic medicament |
| 11/23/2005 | EP1597270A2 Peptidomimetic inhibitors of stat3 activity and their medical uses |
| 11/23/2005 | EP1597262A2 Substituted heterocycles |
| 11/23/2005 | EP1597258A2 Novel purine derivatives, preparation method thereof, application of same as medicaments, pharmaceutical compositions and novel use |
| 11/23/2005 | EP1597256A1 N-heterocyclyl-substituted amino-thiazole derivatives as protein kinase inhibitors |
| 11/23/2005 | EP1597255A1 Rhodanine derivatives and pharmaceutical compositions containing them |
| 11/23/2005 | EP1597253A2 Compounds and methods of treating cell proliferative diseases, retinopathies and arthritis |
| 11/23/2005 | EP1597251A2 Pyrimidine compounds |
| 11/23/2005 | EP1597240A1 Bicyclic heterocycles, medicaments containing said compounds, use thereof, and method for the production thereof |
| 11/23/2005 | EP1597239A1 Polymorph of {6,7-bis(2-methoxy-ethoxy)-quinazolin-4-yl}-(3e) |
| 11/23/2005 | EP1597231A1 Derivatives of azasugars as anticancer agents |
| 11/23/2005 | EP1596885A2 Uses of anti-insulin-like growth factor i receptor antibodies |
| 11/23/2005 | EP1596878A2 Anti-angiogenic and anti-tumoral properties of beta and gamma secretase inhibitors |
| 11/23/2005 | EP1596874A1 Method for treating liver cancer by intrahepatic administration of nemorubicin |
| 11/23/2005 | EP1596857A2 Chroman-derived anti-androgens for the treatment of androgen-mediated disorders |
| 11/23/2005 | EP1596848A1 Use of 1-(2-chloroethyl)-1-nitroso-3-(2-hydroxyethyl)-urea for the treatment of pancreatic cancer, soft-tissue sarcoma, testicular tumors, lymphoma, thymoma, wilm's tumors, renal carcinoma, melanoma, lung cancer, intracerebral metastasis, tumors in the head and neck region, and mammary carcinoma |
| 11/23/2005 | EP1596839A2 Semi-solid immediate-release oral formulations comprising an anticancer hydrophobic agent, a polyglycolised glyceride and a hydrophilic carrier |
| 11/23/2005 | EP1596815A2 Composition and methods for inhibiting cell survival |
| 11/23/2005 | EP1596811A2 Compositions and methods to modulate immune and inflammatory responses |
| 11/23/2005 | EP1596806A2 Compositions and methods for treating cancer using igsf9 and liv-1 |
| 11/23/2005 | EP1596656A2 Pyrazoles and methods of making and using the same |
| 11/23/2005 | EP1578459A3 Apparatus and method for immunotherapy of a cancer through controlled cell lysis |
| 11/23/2005 | EP1546196A4 Marker for cancer |
| 11/23/2005 | EP1444347B1 METHOD FOR THE IN VITRO SYNTHESIS OF SHORT DOUBLE STRANDED RNAs |
| 11/23/2005 | EP1383872B1 Genetically modified yt cell line and use thereof |
| 11/23/2005 | EP1335898B1 Carbamic acid compounds comprising an amide linkage as hdac inhibitors |
| 11/23/2005 | EP1328276B1 Use of antiprogestins for prophylaxis and treatment of hormone-dependent diseases |
| 11/23/2005 | EP1320522B1 Compositions and methods of the use thereof achiral analogues of cc-1065 and the duocarmycins |
| 11/23/2005 | EP1200831B1 Modulating binding site on potassium channels used for screening |
| 11/23/2005 | EP1165071B1 Improved cancer treatment with temozolomide |
| 11/23/2005 | EP1140291B1 Combination chemotherapy comprising a mitotic inhibitor and a mek inhibitor |
| 11/23/2005 | EP1140028B1 Biodegradable poly(phosphoester) compositions for treating ovarian cancer |
| 11/23/2005 | EP1117767B1 Immunomodulation by genetic modification of dendritic cells and b-cells |
| 11/23/2005 | EP1089739B1 Cyclophosphamide coated tablets |
| 11/23/2005 | EP1039930B1 ADJUVANTED VACCINE COMPRISING AN ANTIGEN FROM STREPTOCOCCUS PNEUMONIAE AND A CpG OLIGONUCLEOTIDE |
| 11/23/2005 | EP1001797B9 Soya extract, process for its preparation and pharmaceutical composition |
| 11/23/2005 | EP0939817B1 High-affinity interleukin-4 muteins |
| 11/23/2005 | EP0938474B1 Cyclopropylindole compounds and their use as prodrugs |
| 11/23/2005 | EP0906088B1 Liposomal antineoplaston therapies with markedly improved antineoplastic activity |
| 11/23/2005 | EP0781344B1 Novel implant and novel vector for the treatment of acquired diseases |
| 11/23/2005 | EP0770129B1 Zinc finger protein derivatives and methods therefor |
| 11/23/2005 | EP0732934B1 Long-acting injection suspensions of an lhrh analogue and a process for their preparation |
| 11/23/2005 | CN1701121A Improved transfection of eukaryontic cells with linear polynucleotides by electroporation |
| 11/23/2005 | CN1701074A Novel pyrazolopyrimidines as cyclin dependent kinase inhibitors |